Suppr超能文献

[幽门螺杆菌感染的十二指肠溃疡患者接受奥美拉唑、克拉霉素和阿莫西林治疗6天]

[Treatment with omeprazole, clarithromycin and amoxicillin over 6 days in patients with Helicobacter pylori-infected duodenal ulcer].

作者信息

García-Romero E, del Val A, Garrigues V, Cuquerella J, Higón M D, Barrachina M, Pons V, Bixquert M, Ponce J

机构信息

Hospital Gran Vía, Valencia.

出版信息

Gastroenterol Hepatol. 1999 Jan;22(1):1-6.

Abstract

OBJECTIVE

To investigate the eradication rate of Helicobacter pylori with omeprazole, amoxicillin and clarithromycin during 6 days in patients with duodenal ulcer. To compare the reliability of the analysis of the eradication with urea-13C breath test performed one month and 3 months after therapy. To evaluate the one-year reinfection rate.

PATIENTS AND METHODS

Prospective study including 99 patients with duodenal ulcer (65 with acute disease and 34 in maintenance treatment) infected by Helicobacter pylori (urease rapid test and urea-13C breath test positive). Patients were treated with omeprazole 20 mg, clarithromycin 500 mg and amoxicillin 1 g, b.i.d., during 6 days. The infection status was investigated 1 and 3 months after treatment by urea-13C breath test. The one-year reinfection rate was investigated using the same test.

RESULTS

Per protocol eradication rates were 76% (95%-CI: 66-84) one month and 73% (95%-CI: 63-81) 3 months after treatment. In the intention to treat analysis, eradication rates were 74% (95%-CI: 64-82) and 70% (95%-CI: 60-79), respectively. Side effects were mild and uncommon. The rate of false negative urea-13C breath test results one month after therapy with respect to 3 months was 4.2% (95%-CI: 0.8-11.7). One-year reinfection rate determined in 56 patient was absent.

CONCLUSIONS

The eradication of Helicobacter pylori with triple therapy for 6 days in patients with duodenal ulcer is not satisfactory. To investigate Helicobacter pylori infection with urea-13C breath test one month after treatment overestimates the results of the eradication. One-year reinfection rate is clinically irrelevant.

摘要

目的

研究十二指肠溃疡患者使用奥美拉唑、阿莫西林和克拉霉素治疗6天对幽门螺杆菌的根除率。比较治疗后1个月和3个月进行的尿素-13C呼气试验分析根除情况的可靠性。评估一年的再感染率。

患者与方法

前瞻性研究纳入99例幽门螺杆菌感染(尿素酶快速试验和尿素-13C呼气试验阳性)的十二指肠溃疡患者(65例急性病患者和34例维持治疗患者)。患者接受奥美拉唑20mg、克拉霉素500mg和阿莫西林1g,每日2次,共治疗6天。治疗后1个月和3个月通过尿素-13C呼气试验调查感染状况。使用相同试验调查一年的再感染率。

结果

根据方案分析,治疗后1个月的根除率为76%(95%可信区间:66-84),3个月为73%(95%可信区间:63-81)。在意向性治疗分析中,根除率分别为74%(95%可信区间:64-82)和70%(95%可信区间:60-79)。副作用轻微且不常见。治疗后1个月相对于3个月尿素-13C呼气试验结果的假阴性率为4.2%(95%可信区间:0.8-11.7)。在56例患者中确定的一年再感染率为零。

结论

十二指肠溃疡患者使用三联疗法治疗6天对幽门螺杆菌的根除效果不理想。治疗后1个月用尿素-13C呼气试验调查幽门螺杆菌感染会高估根除结果。一年的再感染率在临床上无意义。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验